captopril test

PreclinicalSmall molecule

NNational Taiwan University Hospital

captopril test is one of 14 small molecule programs targeting Primary Aldosteronism. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Primary AldosteronismActive, not recruiting

Primary AldosteronismPreclinical

Active, not recruiting

Competition

Competitive Landscape

17 competitors in Primary Aldosteronism

#DrugCompanyPhaseTrials

Kerendia

Bayer

Approved

6 2

Inspra

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Approved

3 3

Parlodel

VVeroScience

Approved

1 4

Baxfendy

AstraZeneca

Phase 3

1 5

Aldactone

Pfizer

Preclinical

4 6

Adrenocorticotropic Hormone

Astellas

Preclinical

1 7

Intensive BP Control

SSecond Affiliated Hospital of Nanchang University

Preclinical

1 8

Mineralocorticoid Receptor Antagonists

UUniversity of Pennsylvania

Preclinical

1 9

Nifedipine ER

MMedical College of Wisconsin

Preclinical

1 10

CS-3150

Daiichi Sankyo

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Primary Aldosteronism1 trial

Diagnosis of Primary Aldosteronism: Comparison of Post Captopril Active Renin Concentration and Plasma Renin Activity

Unknown status·NNational Taiwan University Hospital··NCT00917345·150 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for captopril test. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — captopril test compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for captopril test. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — National Taiwan University Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: NNational Taiwan University Hospital

captopril test

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Primary Aldosteronism1 trial

References

Drug Info

Quick Facts

Related News